|
Volumn 43, Issue 2, 2011, Pages 469-471
|
Obesity in renal transplantation: The role of induction therapy on long-term outcomes
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BASILIXIMAB;
THYMOCYTE ANTIBODY;
ADULT;
BODY MASS;
CONFERENCE PAPER;
DRUG EFFECT;
DRUG EFFICACY;
GRAFT SURVIVAL;
HUMAN;
KIDNEY GRAFT REJECTION;
KIDNEY TRANSPLANTATION;
LOW DRUG DOSE;
MAJOR CLINICAL STUDY;
NEOPLASM;
OBESITY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
SURVIVAL TIME;
WOUND INFECTION;
ADULT;
ANIMALS;
ANTIBODIES, MONOCLONAL;
ANTILYMPHOCYTE SERUM;
BODY MASS INDEX;
FEMALE;
GRAFT SURVIVAL;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
MODELS, STATISTICAL;
OBESITY;
RABBITS;
RECOMBINANT FUSION PROTEINS;
TREATMENT OUTCOME;
WOUND HEALING;
|
EID: 79953206620
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2011.01.040 Document Type: Conference Paper |
Times cited : (16)
|
References (10)
|